Tyloxapol
Alternative Names: SuperVentLatest Information Update: 24 Nov 2003
At a glance
- Originator Charlotte-Mecklenberg Hospital Authority
- Developer Charlotte-Mecklenberg Hospital Authority; Discovery Laboratories; University of Utah
- Class Expectorants; Surfactants
- Mechanism of Action Antioxidants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Bronchitis; Cystic fibrosis